Study utilizes UK Biobank data to explore the long-term psychiatric effects of COVID-19 and assesses the role of vaccination in mitigating mental health complications, revealing increased risks for various psychiatric disorders among survivors.
BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001 | Psychedelic Invest
BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic derivative of lysergic acid